Friday, April 25, 2025 - The Pharmacy and Poisons Board (PPB) has issued a warning against the use, sale, distribution and issuance of several pharmaceutical products found to be substandard or falsified.
In a statement to Kenyans, PPB CEO Fred Siyoi highlighted
quality concerns involving three batches of paracetamol 1000mg/100ml injection,
one batch of S-Prazo (Esomeprazole 40mg), and three batches of Augmentin.
The affected paracetamol batches include Lumidol Injection
(Batch Nos. CM4594007, CM4594008, CM4594009), Blink Injection (Batch Nos.
CS4594005, CS4594004), and Paragen Injection (Batch No. K4290027), all
manufactured by KamlaAmrut Pharmaceutical India. The products exhibited unusual
colour changes, prompting concerns over their safety.
The board also recalled S-Prazo (Esomeprazole 40mg), Batch
No. SPZ404, manufactured by Medico Remedies Pharmaceutical India, after a strip
of Levofloxacin 500mg tablets was found inside a pack of the esomeprazole
capsules.
In addition, Augmentin 1G (Batch No. SHS2) and Augmentin
625MG (Batch Nos. 8X3K and EU7C) were identified as falsified products
circulating in the Kenyan market.
“These products pose potential health risks and should not
be used,” said Siyoi, urging the public and healthcare professionals to
immediately stop using the listed medicines.
He further instructed all pharmaceutical outlets and health
facilities to return the affected batches to suppliers or the nearest
healthcare facility without delay.
Paracetamol is commonly used to relieve pain and reduce
fever, while S-Prazo and Augmentin are used to treat acid-related conditions
and bacterial infections, respectively.
The Kenyan DAILY POST
Go and Subscribe to our YouTube
Channel and get the best videos around the country, go HERE>>>
0 Comments